NCT03900130

Brief Summary

Designing food and drink that maximizes satiety has long been an ambition of industry and public health. For obvious reasons, foods that fill faster and for longer are desirable to consumers for controlling their weight, and to public health programs that are designed to prevent obesity. Current methods for measuring satiety have weak predictive value, commonly fail to replicate, and are yet to be validated with respect to energy consumption in everyday life. The investigators propose to overcome this deficiency by developing the Omnibus Satiety Metric (OmniSaM). OmniSaM is proposed as a multi-modal metric that targets the full spectrum of processes underlying the satiety cascade, composing brain, blood, mind and behavior of consumers. As a proof-of-concept, subjects (normal BMI) will undergo a preload ad libitum paradigm, with a 2-parameter factorial design comparing milk based products differing in levels of caloric load and protein-to-carbohydrate ratio. The investigators will acquire 1. high-resolution neuroimaging data, whilst 2. simultaneously recording appetitive hormones, 3. blood metabolite composition, 4. subjective sensory indices of appetite and 4. behavioral metrics of consumption.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 18, 2017

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

March 25, 2019

Completed
7 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 2, 2019

Completed
Last Updated

September 25, 2019

Status Verified

September 1, 2019

Enrollment Period

1.5 years

First QC Date

March 25, 2019

Last Update Submit

September 24, 2019

Conditions

Keywords

hunger, satiety, satiety cascade, satiating capacity

Outcome Measures

Primary Outcomes (1)

  • Ad libitum energy consumption

    The energy content in calories of the spaghetti consumed under ad libitum conditions

    3 hours after the preload

Study Arms (1)

Full group

EXPERIMENTAL

There is only one arm in this study. The group of 25 subjects all undergo a repeated measures 2 x 2 factorial design, fully crossed such that all subjects are tested under all four combinations of factors. The intervention "Preload" amounts to two factors, caloric load and protein to carbohydrate ratio of the preload, both of which can take on two levels high or low.

Dietary Supplement: Preload

Interventions

PreloadDIETARY_SUPPLEMENT

In the 2 x 2 factorial design we vary two factors: 1. caloric load of the preload such that it is either high calorie or low. 2. protein to carbohydrate ratio of the preload such that it is either high or low

Full group

Eligibility Criteria

Age20 Years - 40 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy male
  • Aged 20-40 years old
  • Normal hematology, kidney and liver function
  • Normal weight (BMI 18.5-24.9)
  • Weight stable defined as +/- 5 kg within 3 months prior to test start
  • Liking milk
  • Liking spaghetti bolognaise

You may not qualify if:

  • Suffer or have suffered from any metabolic disorders
  • Suffer or have suffered from any psychiatric disorders
  • Suffer or have suffered from any neurological disorders
  • Restrained eating behavior or caloric restriction
  • Claustrophobia
  • Implanted with pacemakers or other implanted electronic devices
  • Concentration of hemoglobin \<8mMol/L,
  • Alanintransaminase \>70 U/L
  • Alkaline phosphatase \>105 U/L
  • Bilirubin \>25 micromol/L
  • Coagulationfactors (INR) \>1.2
  • eGFR \<60 ml/min
  • hba1c \>48 mmol/mol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oliver Hulme

København S, Region Sjælland, 2300, Denmark

Location

MeSH Terms

Conditions

Behavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
The study is a repeated measures design. It is double blinded in the sense that the participant, brain imager and endocrinologist are masked from the preload condition. One technician is unblinded as to the preload type. The participant is not aware of the possible ways in which the preload can vary, or even that it could vary over testdays.
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: Repeated measures, fully crossed, factorial design with caloric load and protein to carbohydrate ratio of preload as 2-level factors.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 25, 2019

First Posted

April 2, 2019

Study Start

October 18, 2017

Primary Completion

April 1, 2019

Study Completion

April 1, 2019

Last Updated

September 25, 2019

Record last verified: 2019-09

Locations